BriaCell Therapeutics (BCTXZ) Stock Price, Quote, News & History

BriaCell Therapeutics Corp (BCTXZ) Stock Price, Quote, News & History

BCTXZNASDAQ

Trade with Public

$0.1488

At close: Mar 13, 5:00 PM EST

Key Statistics

Open

Volume / Avg.

0 / 13.83K

Day Range

- - -

52 Wk Range

0.06 - 15.15

Market Cap

$346.85K

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

Recent Briacell Therapeutics Corp News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-28.92M

Investing Cash Flow (TTM)

-7.65M

Financing Cash Flow (TTM)

33.49M

Free Cash Flow (TTM)

-28.92M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-3.08M

Valuation Metrics

Enterprise Value

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$2.71M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

Volume / Avg.

0 / 13.83K

Day Range

- - -

52 Wk Range

0.06 - 15.15

Market Cap

$346.85K

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherap...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy BriaCell Therapeutics (BCTXZ) stock?

You can purchase shares of BriaCell Therapeutics (NASDAQ:BCTXZ) through any online brokerage.

View our list of the best stock brokerages

Who are BriaCell Therapeutics (BCTXZ) competitors?

Other companies in BriaCell Therapeutics’s space includes: Bone Biologics Corp (NASDAQ:BBLG), AIM ImmunoTech Inc (AMEX:AIM), Ernexa Therapeutics Inc (NASDAQ:ERNAW), Azitra Inc (AMEX:AZTR) and Scinai Immunotherapeutics Ltd (NASDAQ:SCNI).

What is the forecast, or price target, for BriaCell Therapeutics (BCTXZ) stock?

There is no analysis for BriaCell Therapeutics to provide a consensus price target.

What is the current price for BriaCell Therapeutics (BCTXZ)?

The stock price for BriaCell Therapeutics (NASDAQ: BCTXZ) is $0.1488 last updated March 12, 2026 at 11:17 AM EDT.

Does BriaCell Therapeutics (BCTXZ) pay a dividend?

There are no upcoming dividends for BriaCell Therapeutics.

When is BriaCell Therapeutics (NASDAQ:BCTXZ) reporting earnings?

BriaCell Therapeutics does not have any upcoming earnings scheduled.

Is BriaCell Therapeutics (BCTXZ) going to split?

There is no upcoming split for BriaCell Therapeutics.

What sector and industry does BriaCell Therapeutics (BCTXZ) operate in?

BriaCell Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

ERNAW

AZTR

Scinai Immunotherapeutics Ltd

bioAffinity Technologies Inc

NASDAQ:BIAFW

$0.31

No data available

Sunshine Biopharma Inc

NASDAQ:SBFMW

$0.07

-27.55%

Key Statistics

Open

Volume / Avg.

0 / 13.83K

Day Range

- - -

52 Wk Range

0.06 - 15.15

Market Cap

$346.85K

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

Recent Briacell Therapeutics Corp News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-28.92M

Investing Cash Flow (TTM)

-7.65M

Financing Cash Flow (TTM)

33.49M

Free Cash Flow (TTM)

-28.92M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-3.08M

Valuation Metrics

Enterprise Value

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$2.71M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

Volume / Avg.

0 / 13.83K

Day Range

- - -

52 Wk Range

0.06 - 15.15

Market Cap

$346.85K

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry